Danish pharmaceutical giant Novo Nordisk on Tuesday cuts its full-year sales and profit guidance.

Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved Wegovy® through NovoCa...

SAN FRANCISCO, June 25, 2025 /PRNewswire/ -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shar...

While most side effects are likely to disappear when the medication is stopped, any damage to the teeth is permanent

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug...

While most side effects are likely to disappear when the medication is stopped, any damage to the teeth is permanent

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for millions. Dr. Celine G...

Noom will start offering microdoses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health company continues to...

Colorado has reversed course and decided to continue covering the cost of GLP-1 medications for state employees who are already using the cl...

Days earlier, Novo Nordisk cut its sales and profit forecast for first time since the launch of Wegovy four years ago.

The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post "for a period to support a smooth transition to new leade...

By Naomi Kresge | BloombergEli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nord...

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s d...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head...

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand in the U.S....